From Ganfyd

Jump to: navigation, search

The CHM gene at Xq21.2 codes for the 653 amino acid Rab proteins geranylgeranyltransferase component A 1. There are two known isoforms and one forms the substrate-binding subunit of the Rab geranylgeranyltransferase (GGTase) trimer complex.

Dysfunctional mutations cause choroideremia (OMIM:303100)[1], an X-linked recessive disease characterized by a slowly progressive degeneration of the choroid, photoreceptors, and retinal pigment epithelium. Presentation is typically with night blindness in teenage males followed by loss of peripheral vision and complete blindness by middle age. Carrier females are generally asymptomatic but fundoscopic examination may show patchy areas of chorioretinal atrophy. The standard of care in males seems increasingly likely to include gene therapy with nonmutated CHM in an AAV vector (AAV.REP1) by subfoveal injection as in 2016 it was reported that preserved if not improved visual function at 3.5 year follow up had occurred[2].